These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 2538095)

  • 61. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.
    Haumont M; Jurdan M; Kangro H; Jacquet A; Massaer M; Deleersnyder V; Garcia L; Bosseloir A; Bruck C; Bollen A; Jacobs P
    J Med Virol; 1997 Sep; 53(1):63-8. PubMed ID: 9298734
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group.
    Hardy I; Gershon AA; Steinberg SP; LaRussa P
    N Engl J Med; 1991 Nov; 325(22):1545-50. PubMed ID: 1658650
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study.
    Baba K; Yabuuchi H; Takahashi M; Ogra PL
    J Pediatr; 1986 Mar; 108(3):372-7. PubMed ID: 3005536
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunization of the elderly and patients with collagen vascular diseases with live varicella vaccine and use of varicella skin antigen.
    Takahashi M; Iketani T; Sasada K; Hara J; Kamiya H; Asano Y; Baba K; Shiraki K
    J Infect Dis; 1992 Aug; 166 Suppl 1():S58-62. PubMed ID: 1320651
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Seroepidemiology of varicella-zoster virus antibodies among health-care workers and day-care-centre workers.
    Lerman Y; Chodick G; Tepper S; Livni G; Ashkenazi S
    Epidemiol Infect; 2004 Dec; 132(6):1135-8. PubMed ID: 15635972
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 67. IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster.
    Gershon AA; Steinberg SP; Borkowsky W; Lennette D; Lennette E
    Pediatr Infect Dis; 1982; 1(3):164-7. PubMed ID: 6292875
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Varicella-zoster virus immunity in dermatological patients on systemic immunosuppressant treatment.
    Hackett CB; Wall D; Fitzgerald SF; Rogers S; Kirby B
    Br J Dermatol; 2011 Jun; 164(6):1387-9. PubMed ID: 21410679
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Varicella-zoster virus infection in children with underlying human immunodeficiency virus infection.
    Gershon AA; Mervish N; LaRussa P; Steinberg S; Lo SH; Hodes D; Fikrig S; Bonagura V; Bakshi S
    J Infect Dis; 1997 Dec; 176(6):1496-500. PubMed ID: 9395360
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Congenital varicella-zoster virus infection and the failure to establish virus-specific cell-mediated immunity.
    Grose C
    Mol Biol Med; 1989 Oct; 6(5):453-62. PubMed ID: 2560525
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Western blot analysis of antibody to varicella-zoster virus.
    Dubey L; Steinberg SP; LaRussa P; Oh P; Gershon AA
    J Infect Dis; 1988 May; 157(5):882-8. PubMed ID: 2834466
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Infection and persistence of varicella-zoster virus in lymphoblastoid Raji cell line.
    Leventon-Kriss S; Gotlieb-Stematsky T; Vonsover A; Smetana Z
    Med Microbiol Immunol; 1979; 167(4):275-83. PubMed ID: 232537
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Live attenuated varicella vaccine.
    Arvin AM; Gershon AA
    Annu Rev Microbiol; 1996; 50():59-100. PubMed ID: 8905076
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Varicella-zoster virus infections in the immunocompromised host. Natural history and treatment.
    Balfour HH
    Scand J Infect Dis Suppl; 1991; 80():69-74. PubMed ID: 1666447
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Varicella zoster antibodies after herpes zoster, varicella and multiple sclerosis.
    Ross RT; Nicolle LE; Dawood MR; Cheang M; Feschuk C
    Can J Neurol Sci; 1997 May; 24(2):137-9. PubMed ID: 9164691
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Susceptibility to varicella virus of certain adults in the southeastern United States.
    Hyams PJ; Vernon S; Eckert D
    Am J Infect Control; 1984 Feb; 12(1):6-9. PubMed ID: 6322621
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Common expression of varicella-zoster viral glycoprotein antigens in vitro and in chickenpox and zoster vesicles.
    Weigle KA; Grose C
    J Infect Dis; 1983 Oct; 148(4):630-8. PubMed ID: 6313814
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Varicella vaccination for healthcare workers at a university hospital: an analysis of costs and benefits.
    Tennenberg AM; Brassard JE; Van Lieu J; Drusin LM
    Infect Control Hosp Epidemiol; 1997 Jun; 18(6):405-11. PubMed ID: 9181396
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation.
    Weigle KA; Grose C
    J Infect Dis; 1984 May; 149(5):741-9. PubMed ID: 6327848
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Complications in two children with acute lymphatic leukemia caused by vaccination against varicella zoster virus].
    Christensen CL; Poulsen A; Böttiger B; Kirk M; Andersen HK; Schmiegelow K
    Ugeskr Laeger; 1999 Feb; 161(6):794-6. PubMed ID: 10068350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.